INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,071 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
8,135 sh
Jan 23, 2026Jan 27, 2026
Page 1662 of 2052
← PrevNext →
traded Jan 23, 2026
+4d
SEC Form 4

Evidence

62
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$281K
28.1K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

59
RG
Rooney Robert GeraldDirector
NONENONETCW Private Asset Income Fund
Open-market purchase
BUY$113K
11.3K sh
Nov 10, 2025Jan 26, 2026
traded Nov 10, 2025
+77dSEC Form 4

Evidence

41
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$114K
5,000 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

36
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Derivative conversion
C—
200.0K sh
Nov 26, 2025Jan 26, 2026
traded Nov 26, 2025
+61dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$3.32M
8,500 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$2.00M
19.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$1.99M
5,128 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$2.81M
7,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
TA
Tpg Gp A, Llc10% Owner
SIONSionna Therapeutics, Inc.
Open-market sale
SELL$10.00M
250.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$777K
1,577 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$864K
2,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$500K
4,765 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
WA
Wilson Kelli AnnEVP Chief Banking Officer
HFWAHERITAGE FINANCIAL CORP /WA/
Open-market sale
SELL$50K
1,900 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$511K
1,295 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$911K
2,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

30
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$319K
647 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

30
IJ
Idell JenniferChief Administrative Officer
SSBSouthState Bank Corp
Grant or award
A$144K
1,485 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

29
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$1.90M
54.3K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$15.61M
115.6K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Grant or award
A$27K
282 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

26
SJ
Singh Harmit JEVP & Chief Fin. & Growth Ofc.
LLEVILEVI STRAUSS & CO
Tax withholding
F$2.33M
107.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

26
IJ
Idell JenniferChief Administrative Officer
SSBSouthState Bank Corp
Grant or award
A$216K
2,227 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

26
GM
Gass MichelleDirector, President & CEO
LEVILEVI STRAUSS & CO
Tax withholding
F$2.58M
119.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

25
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$282K
570 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

24
HD
Hahnfeld Jeffrey DEVP-CONTROLLER & CHIEF ACC OFF
WTFCWINTRUST FINANCIAL CORP
Grant or award
A$166K
1,088 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

24
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Derivative conversion
C—
200.0K sh
Nov 26, 2025Jan 26, 2026
traded Nov 26, 2025
+61dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$60K
214 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

23
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Grant or award
A$41K
423 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

23
SM
Spurgin Jim MarkSVP Chief Supply Chain Officer
CBRLCRACKER BARREL OLD COUNTRY STORE, INC
Tax withholding
F$10K
318 sh
Jan 17, 2026Jan 26, 2026
traded Jan 17, 2026
+9dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$172K
610 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

22
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
5,000 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$805K
20.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,116 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Grant or award
A—
11.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SJ
Singh Harmit JEVP & Chief Fin. & Growth Ofc.
LLEVILEVI STRAUSS & CO
Grant or award
A—
213.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
GC
Gowasack Andrew CarlDirector, President
IDAIT Stamp Inc
Grant or award
A—
68.4K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,500 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence